American Health Packaging Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: American Health Packaging Pharmaceutical Import Records from India — 2 Products, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

American Health Packaging — Pharmaceutical Importer Profile (2026) | 2 Products, $1.9M Trade | TransData Nexus

American Health Packaging

Pharmaceutical Importer · United States · Advanced Antibiotics Focus · $1.9M Total Trade · DGFT Verified

American Health Packaging is a pharmaceutical importer based in United States with a total trade value of $1.9M across 2 products in 2 therapeutic categories. Based on 37 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. American Health Packaging sources from 9 verified Indian suppliers, with Msn Laboratories Private Limited accounting for 55.1% of imports.

American Health Packaging — Import Portfolio & Supplier Network

American Health Packaging import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to American Health Packaging?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Msn Laboratories Private Limited	$1.8M	39	55.1%
Mankind Pharma Limited	$582.0K	20	17.9%
Granules India Limited

What Formulations Does American Health Packaging Import?

Formulation	Value	Ships
Potassium ertab20meq 500	$350.0K	7
Paclitaxel INJ 300MG /50ML(msn pharmaceutical product name	$350.0K	7
Msn pharma paclitaxel INJ 300MG /50ML	$300.0K	6
Abiraterone TAB bluepoint 250MG 120 s(msn pharmaceutical product name	$213.1K	5
Potassium ertab10meq100 726 (10464 x	$182.6K	7
Abiraterone TAB bluepoint 250 MG 120	$152.3K	4
Abiraterone TAB bluepoint 250MG 120 s msn pharmaceutical product	$150.0K	3
Nitrofurantoin capsules USP (monohydrate/macrocrystals) 100MG [16968 packs x 100's] [batch no. at0x001 mfg. dt. 01/24	$139.0K	3
Abiraterone TAB bluepoint 250MG 120s	$100.0K	2
Linezolid oral suspension	$100.0K	2
Paclitaxel INJ 300MG /50ML	$100.0K	2
Bortezomib injection 3.5MG 1's	$73.4K	2
Peg 3350 pfos (polyethylene glycol oralsuspension solution)	$73.2K	4
51000487- fosaprepitant for injection	$50.0K	1
Nitrofurantoin CAPS USP macrocrystals50mg 100s bt no.aq23w001 manufacturing .jul-2023 exp.jun-2025 ndc	$50.0K	1

American Health Packaging imports 41 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Nitrofurantoin	Advanced Antibiotics	$950.0K	19	2.8%	3
2	Paclitaxel	Oncology	$900.0K	18	1.1%	8

American Health Packaging imports 2 pharmaceutical products across 2 categories into United States totaling $1.9M.

American Health Packaging — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

American Health Packaging (AHP), headquartered in Columbus, Ohio, is a leading manufacturer specializing in serialized, barcoded unit-dose pharmaceutical products. Serving hospital, institutional, and long-term care pharmacies across the United States, AHP offers a comprehensive portfolio of unit-dose oral solids and liquids. Their product line includes oral solids, liquid unit-dose cups, inhalants, and powder/granule oral suspensions, all designed to meet the dynamic needs of healthcare facilities.

With over 30 years of experience, AHP's manufacturing facility is registered with the Food and Drug Administration (FDA) and fully adheres to current Good Manufacturing Practices (cGMP). The company is also licensed by the Drug Enforcement Administration (DEA) to package Schedule II-V controlled substances. This extensive experience underscores AHP's commitment to quality and compliance in the pharmaceutical industry.

2Distribution Network

AHP operates a centralized distribution facility in Columbus, Ohio, strategically located to serve the U.S. healthcare market efficiently. The facility is registered with the FDA and adheres to cGMP standards, ensuring the quality and safety of its products. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, AHP's established infrastructure supports nationwide distribution through partnerships with Group Purchasing Organizations (GPOs) and wholesalers.

3Industry Role

In the U.S. pharmaceutical supply chain, AHP functions primarily as a manufacturer and distributor of unit-dose medications. By producing and supplying barcoded unit-dose products, AHP plays a crucial role in enhancing medication safety and efficiency within hospital and long-term care pharmacy settings. Their focus on serialized, barcoded unit-dose products aligns with industry efforts to improve patient safety and streamline medication administration processes.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — American Health Packaging

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

AHP's sourcing strategy reveals a significant concentration in its supplier base, with nine verified Indian suppliers accounting for a total import value of $1.9 million USD over 37 shipments. The top five products imported—Nitrofurantoin and Paclitaxel—comprise 100% of the portfolio, indicating a highly concentrated product range. This concentration suggests a strategic focus on specific therapeutic areas, potentially leveraging supplier expertise and cost efficiencies. However, such dependency may pose risks related to supply chain disruptions or regulatory changes affecting these suppliers.

2Supply Chain Resilience

AHP's supply chain resilience is influenced by its reliance on a limited number of suppliers for a concentrated product portfolio. While this approach may streamline operations and reduce costs, it also exposes AHP to potential risks associated with supplier disruptions, geopolitical issues, or regulatory changes in the suppliers' home countries. The company's adherence to cGMP and DEA regulations indicates a commitment to quality and compliance, which is essential for maintaining supply chain integrity.

3Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing pharmaceutical imports. Key legislation governing these imports includes the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets standards for drug safety, efficacy, and labeling. The Drug Supply Chain Security Act (DSCSA) further enhances the FDA's ability to track and trace drugs as they move through the supply chain, aiming to protect consumers from counterfeit and substandard drugs.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. include registration of foreign drug establishments with the FDA and listing of all drug products intended for U.S. distribution. Manufacturers must comply with current Good Manufacturing Practices (cGMP) to ensure product quality and safety. Recognition of cGMP certificates from other jurisdictions, such as EU GMP, WHO GMP, or PIC/S, may be accepted, but compliance with FDA-specific requirements is mandatory. Additionally, wholesale distribution authorization is required for entities involved in the distribution of pharmaceutical products within the U.S.

3Quality & Labeling

American Health Packaging — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

AHP's focus on advanced antibiotics and oncology products aligns with the high demand for these therapeutic areas in the U.S. healthcare system. The importation of Nitrofurantoin and Paclitaxel addresses critical needs in treating infections and cancer, respectively. This strategic product selection reflects AHP's commitment to providing essential medications that support patient care and meet market demands.

2Sourcing Profile

AHP's sourcing strategy emphasizes generic drug formulations, particularly in the advanced antibiotics and oncology categories. By importing these products from India, AHP leverages cost-effective manufacturing while ensuring compliance with U.S. regulatory standards. This approach allows AHP to offer essential medications at competitive prices, benefiting both healthcare providers and patients.

3Market Positioning

AHP serves the U.S. pharmaceutical market by supplying unit-dose medications to hospital and long-term care pharmacies. Their focus on advanced antibiotics and oncology products positions them as a key supplier of essential medications in these therapeutic areas. By providing high-quality, barcoded unit-dose products, AHP enhances medication safety and administration efficiency within healthcare facilities.

Seller's Guide — How to Become a Supplier to American Health Packaging

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter AHP's supply chain by meeting the company's stringent quality standards and regulatory requirements. Potential suppliers should focus on producing high-quality generic formulations in the advanced antibiotics and oncology categories. Establishing strong relationships with AHP and ensuring compliance with FDA regulations will be crucial for success.

2Requirements & Qualifications

Indian exporters seeking to supply AHP and the U.S. market must obtain FDA registration and listing for their drug products. Compliance with cGMP is mandatory, and recognition of cGMP certificates from other jurisdictions may be accepted. Additionally, products must meet FDA labeling requirements, including accurate and truthful information, appropriate language, and serialization mandates. Adherence to these standards is essential for entering the U.S. pharmaceutical market.

3How to Approach

Frequently Asked Questions — American Health Packaging

What products does American Health Packaging import from India?

American Health Packaging imports 2 pharmaceutical products across 2 categories. Top imports: Nitrofurantoin ($950.0K), Paclitaxel ($900.0K).

Who supplies pharmaceuticals to American Health Packaging from India?

American Health Packaging sources from 9 verified Indian suppliers. The primary supplier is Msn Laboratories Private Limited (55.1% of imports, $1.8M).

What is American Health Packaging's total pharmaceutical import value?

American Health Packaging's total pharmaceutical import value from India is $1.9M, based on 37 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does American Health Packaging focus on?

American Health Packaging imports across 2 categories. The largest: Advanced Antibiotics (51.4%), Oncology (48.6%).

Get Full American Health Packaging Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.